BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24357175)

  • 1. [Determination of interval cancer rates in the German mammography screening program using population-based cancer registry data].
    Urbschat I; Heidinger O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):68-76. PubMed ID: 24357175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
    Fuhs A; Bartholomäus S; Heidinger O; Hense HW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of interval cancers in the German mammography screening program: results from the population-based cancer registry in North Rhine-Westphalia.
    Heidinger O; Batzler WU; Krieg V; Weigel S; Biesheuvel C; Heindel W; Hense HW
    Dtsch Arztebl Int; 2012 Nov; 109(46):781-7. PubMed ID: 23264826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological Cancer Registry of North Rhine-Westphalia].
    Kajüter H; Geier AS; Wellmann I; Krieg V; Fricke R; Heidinger O; Hense HW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):52-9. PubMed ID: 24357173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Time trend in programme sensitivity within the German mammography screening programme in North Rhine-Westphalia and Lower Saxony].
    Bokhof B; Khil L; Urbschat I; Gnas L; Hecht G; Heidinger O; Heindel W; Kieschke J; Weigel S; Hense HW
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1517-1527. PubMed ID: 30421287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
    Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
    Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performance of record linkage for cancer registry data linked with mammography screening data].
    Giersiepen K; Bachteler T; Gramlich T; Reiher J; Schubert B; Novopashenny I; Schnell R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jul; 53(7):740-7. PubMed ID: 20652484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Linkage of secondary data with cancer registry data on the basis of encrypted personal identifiers - results from a pilot study in North Rhine-Westphalia].
    Kajüter H; Batzler WU; Krieg V; Heidinger O; Hense HW
    Gesundheitswesen; 2012 Aug; 74(8-9):e84-9. PubMed ID: 22836935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer incidence and mammography screening among resettlers in Germany.
    Kaucher S; Khil L; Kajüter H; Becher H; Reder M; Kolip P; Spallek J; Winkler V; Berens EM
    BMC Public Health; 2020 Mar; 20(1):417. PubMed ID: 32228537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
    Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
    Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Linkage of data of the medical service of the health insurances with data of a cancer registry].
    Breckenkamp J; Spallek J; Kraywinkel K; Krieg V; Schwabe W; Greiner W; Damm O; Hense H; Razum O
    Gesundheitswesen; 2012 Jul; 74(7):e52-60. PubMed ID: 22012561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. German mammography screening program: program sensitivity between 2010 and 2016 estimated based on German health claims data.
    Heinze F; Czwikla J; Heinig M; Langner I; Haug U
    BMC Cancer; 2023 Sep; 23(1):852. PubMed ID: 37697304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assessment of the mammographic screening programme in the Azienda Sanitaria locale Provincia Milano 1 -- analysis of interval cancers and discussion of possible causes of diagnostic error.
    Burani R; Caimi F; Maggioni C; Marinoni G; Pellizzoni R; Pirola ME; Villa R; Ciatto S
    Radiol Med; 2005 Mar; 109(3):260-7. PubMed ID: 15775895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction of a mammography screening program in Germany. Consideration of benefits and risks].
    Nekolla EA; Griebel J; Brix G
    Radiologe; 2005 Mar; 45(3):245-54. PubMed ID: 15717183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands.
    Schouten LJ; de Rijke JM; Schlangen JT; Verbeek AL
    J Med Screen; 1998; 5(1):37-41. PubMed ID: 9575459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).
    Bucchi L; Frigerio A; Zorzi M; Fedato C; Angiolucci G; Bernardi D; Campari C; Crocetti E; Ferretti S; Giorgi D; Marchisio F; Morrone D; Naldoni C; Petrella M; Ponti A; Ravaioli A; Saguatti G; Santini D; Sassoli de Bianchi P; Serafini M; Vergini V; Giordano L
    Epidemiol Prev; 2015; 39(3 Suppl 1):52-7. PubMed ID: 26405777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secure Linking of Data from Population-Based Cancer Registries with Healthcare Data to Evaluate Screening Programs.
    Bartholomäus S; Siegert Y; Hense HW; Heidinger O
    Gesundheitswesen; 2020 Mar; 82(S 02):S131-S138. PubMed ID: 31822021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population.
    Simbrich A; Wellmann I; Heidrich J; Heidinger O; Hense HW
    Cancer Epidemiol; 2016 Oct; 44():44-51. PubMed ID: 27470937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.